Mario Schlosser Sells 34,120 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 34,120 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $748,592.80. Following the transaction, the director directly owned 480,866 shares of the company’s stock, valued at $10,550,200.04. The trade was a 6.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

Shares of Oscar Health stock traded up $3.04 during mid-day trading on Thursday, reaching $23.54. 10,532,228 shares of the stock traded hands, compared to its average volume of 7,845,401. The business has a 50-day moving average of $17.92 and a 200 day moving average of $15.93. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $25.58. The stock has a market capitalization of $7.10 billion, a PE ratio of -39.90, a PEG ratio of 1.48 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business had revenue of $4.65 billion during the quarter, compared to analysts’ expectations of $4.90 billion. During the same quarter in the prior year, the firm earned $0.92 earnings per share. The business’s revenue was up 52.6% compared to the same quarter last year. On average, analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current year.

Wall Street Analysts Forecast Growth

OSCR has been the subject of a number of research analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Tuesday, April 21st. Barclays upped their price target on Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 26th. UBS Group upped their price target on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a research report on Thursday, February 12th. Finally, Wall Street Zen upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Saturday, May 9th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Oscar Health currently has a consensus rating of “Hold” and an average price target of $20.22.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp grew its position in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio purchased a new position in Oscar Health in the first quarter worth approximately $30,000. Fifth Third Bancorp grew its position in Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the period. Quarry LP grew its position in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares during the period. Finally, Tsfg LLC purchased a new position in Oscar Health in the third quarter worth approximately $38,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.